The June 23 2026 edition of the Holland & Knight Health Dose report highlights several significant health policy developments in the United States. These updates cover new legislative proposals and regulatory changes that could affect healthcare providers, insurers, and patients across the country.

Key Takeaways

  • New legislative proposals aim to expand telehealth coverage for Medicare beneficiaries.
  • Regulatory changes are being considered for drug pricing transparency requirements.
  • Updates to hospital payment models may shift how certain services are reimbursed.
  • Proposed rules could strengthen patient data privacy protections under HIPAA.

Telehealth Expansion Legislation

The report notes that lawmakers are considering new bills to permanently extend telehealth flexibilities that were temporarily expanded during the public health emergency. These proposals would allow Medicare beneficiaries to continue receiving telehealth services from their homes rather than requiring them to visit a healthcare facility. Supporters argue this improves access for rural and homebound patients.

According to the Holland & Knight analysis, the legislation faces debate over cost estimates and concerns about potential overuse of remote services. However, the bill has bipartisan support in committee.

Drug Pricing Transparency Rules

Regulatory agencies are reviewing new requirements for drug manufacturers to disclose pricing information. The proposed rules would mandate that companies report list price increases and provide justifications for significant cost changes. The Holland & Knight report indicates that these measures aim to give consumers and insurers more insight into prescription drug costs.

Industry groups have raised concerns about administrative burdens and potential competitive disadvantages. Public comment periods are expected to close in late summer 2026.

Hospital Payment Model Updates

The Centers for Medicare & Medicaid Services (CMS) has proposed adjustments to the Inpatient Prospective Payment System (IPPS). These changes would alter how hospitals are reimbursed for certain procedures and could impact facility budgets. The Holland & Knight report highlights that the proposed rule includes new quality measurement requirements tied to payment incentives.

Hospitals are reviewing the proposal to assess financial implications. The final rule is expected later this year.

Patient Data Privacy Enhancements

New regulatory proposals would strengthen HIPAA protections by expanding the definition of protected health information. The changes would include stricter requirements for patient consent before sharing data with third parties, including health apps and research organizations. The Holland & Knight report notes that these updates respond to growing concerns about digital health privacy.

Healthcare organizations will need to update their compliance programs if the rules are finalized as proposed.

Frequently Asked Questions

What is the Holland & Knight Health Dose report?

The Health Dose is a regular publication from the law firm Holland & Knight that summarizes recent health policy developments. It provides analysis of legislative and regulatory changes affecting the healthcare industry.

How might these policy updates affect patients?

Patients could see expanded access to telehealth services and increased transparency about drug prices. Stronger privacy protections may also give patients more control over their health data.

When will these proposed changes take effect?

Most proposals are still in early stages. Telehealth legislation requires congressional approval, while regulatory changes go through public comment periods. Final implementation timelines vary and may extend into 2027.

This is an original report by Vital Signs Today, informed by reporting from Google News. Read the original source.

This article is for information only and is not medical advice. See our Medical Disclaimer.